의약품 할인 카드 시장 : 유형별, 치료 카테고리별, 판매 채널별, 지역별
Drug Discount Card Market, By Type, By Therapeutic Category, By Sales Channel,, By Geography
상품코드
:
1741461
리서치사
:
Coherent Market Insights
발행일
:
2025년 03월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 의약품 할인 카드 시장 규모는 2025년에는 19억 5,620만 달러로 추정되고, 2032년에는 33억 7,440만 달러에 이를 것으로 예측되며, 2025-2032년의 연간 평균 성장률(CAGR)은 8.1%를 나타낼 전망입니다.
| 보고 범위 |
보고서 세부정보 |
| 기준 연도 |
2024년 |
시장 규모(2025년) |
19억 5,620만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측기간(2025-2032년) CAGR |
8.10% |
가치 예측(2032년) |
33억 7,440만 달러 |
의약품 할인 카드는 소비자가 처방약을 절약하기 위한 일반적인 방법이 되고 있습니다.
시장 역학 :
의약품 할인 카드 시장은 몇 가지 요인에 의해 견인되고 있습니다. 첫째, 저렴한 가격의 건강 옵션에 대한 요구 증가가 의약품 할인 카드의 보급으로 이어졌습니다.
이 시장의 또 다른 성장 촉진요인은 만성 질환의 만연입니다. 만성 질환의 환자 수가 계속 증가함에 따라 처방약 수요도 증가하고 있습니다.
그러나, 시장에는 일정한 억제요인도 존재합니다. 의약품 할인 카드가 직면하는 과제의 하나는 모든 약국에서 받아들여지고 있지 않는 것입니다. 많은 대형 약국이 이러한 카드를 받아들이고 있는 한편, 이러한 프로그램에 참가하고 있지 않은 소규모 약국도 아직 남아 있습니다.
이러한 과제에도 불구하고 의약품 할인 카드 시장에는 큰 기회가 있습니다.
본 조사의 주요 특징
- 본 보고서에서는 2024년을 기준연도로 하여 2025-2032년의 예측 기간에 있어서 시장 규모나 CAGR 등 세계의 의약품 할인 카드 시장을 상세하게 분석했습니다.
- 다양한 부문에서 잠재적인 수익 성장 기회를 찾아 이 시장의 매력적인 투자 제안 매트릭스를 제시합니다.
- 시장 인사이트 : 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향과 성장 촉진요인, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 주요한 인사이트를 제공합니다.
- 기업 프로파일 : GoodRx, SingleCare, WellCard Savings, RxSaver, Optum Perks, Kroger Prescription Savings Club, ScriptSave, Walmart Rx Savings Program, Prescription Hope, FamilyWize, NeedyMeds, Humana 등의 의약품 할인 카드 시장 주요 기업을 기업 하이라이트, 제품 포트폴리오, 재무 실적, 전략 등의 파라미터에 근거해 프로파일 하고 있습니다.
- 이 조사는 마케팅 담당자와 경영진이 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 할 때 도움이 됩니다.
- 이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 업계의 다양한 이해 관계자를 지원합니다.
- 세계의 의약품 할인 카드 시장 분석에는 다양한 전략 매트릭스가 사용되고 있어 이해 관계자의 의사 결정을 용이하게 합니다.
목차
제1장 조사의 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 처방약의 고가격
- 무보험자 및 저보험자 인구가 많음
- 온라인 플랫폼의 온라인 채용 증가
- 의약품의 할인 제공에 있어서의 주정부의 관여
- 주요 인구층에서의 인식의 부족
- 제약회사나 정부기관에 의한 할인 프로그램
- 신흥 시장 진출
- 시판약의 할인 카드
- 고용주를 위한 맞춤형 서비스
- 영향 분석
- 주요 하이라이트
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- Porter's Five Forces 분석
- 합병과 인수 시나리오
제4장 의약품 할인 카드 시장 : COVID-19 팬데믹의 영향
- COVID-19 역학
- 공급측과 수요측의 분석
- 경제에 미치는 영향
제5장 의약품 할인 카드 시장 : 유형별(2020-2032년)
제6장 의약품 할인 카드 시장 : 치료 카테고리별(2020-2032년)
- 심혈관약물
- 당뇨병약물
- 진통제
- 정신과 치료제
- 암 치료제
- 기타
제7장 의약품 할인 카드 시장 : 판매 채널별(2020-2032년)
제8장 의약품 할인 카드 시장 : 지역별(2020-2032년)
- 북미
- 유럽
- 영국
- 독일
- 이탈리아
- 프랑스
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- ASEAN
- 호주
- 한국
- 기타 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
- 이스라엘
- 북아프리카
- 중앙 아프리카
- 기타 중동 및 아프리카
제9장 경쟁 구도
- GoodRx
- SingleCare
- WellCard Savings
- RxSaver
- Optum Perks
- Kroger Prescription Savings Club
- ScriptSave
- Walmart Rx Savings Program
- Prescription Hope
- FamilyWize
- NeedyMeds
- Humana
제10장 섹션
KTH
영문 목차
Drug Discount Card Market is estimated to be valued at USD 1,956.2 Mn in 2025 and is expected to reach USD 3,374.4 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 1,956.2 Mn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
8.10% |
2032 Value Projection: |
USD 3,374.4 Mn |
Drug discount cards have become a popular way for consumers to save money on prescription medications. With rising healthcare costs, these discount cards offer a much-needed financial relief to individuals and families. The concept is simple - individuals can present their drug discount card at participating pharmacies to receive discounted prices on their prescriptions.
Market Dynamics:
The drug discount card market is driven by several factors. Firstly, the increasing need for affordable healthcare options has led to a rise in the adoption of drug discount cards. With rising healthcare costs and high prescription drug prices, consumers are actively searching for ways to save money on their medications.
Another driver of this market is the growing prevalence of chronic diseases. As the number of individuals with chronic illnesses continues to rise, so does the demand for prescription medications. Drug discount cards provide an accessible and affordable solution for individuals who rely on medication to manage their conditions.
However, there are also certain restraints in the market. One of the challenges faced by drug discount cards is the lack of acceptance at all pharmacies. While many major pharmacies accept these cards, there are still some smaller pharmacies that do not participate in such programs. This limited acceptance can be a barrier for consumers who prefer to use local or independent pharmacies.
Despite these challenges, there are significant opportunities in the drug discount card market. The implementation of digital platforms and mobile applications has made it easier for consumers to access and use these cards. With the increasing adoption of smartphones and the convenience of mobile apps, drug discount cards can reach a wider audience and provide even more value to consumers.
Key features of the study:
- The report provides an in-depth analysis of the global drug discount card market including market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
- The study explores potential revenue growth opportunities across different segments and presents attractive investment proposition matrices for this market
- Market Insights: The report presents key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- Company Profiles: Key players in the drug discount card market, such as GoodRx, SingleCare, WellCard Savings, RxSaver, Optum Perks, Kroger Prescription Savings Club, ScriptSave, Walmart Rx Savings Program, Prescription Hope, and FamilyWize, NeedyMeds and Humana are profiled based on parameters like company highlights, product portfolio, financial performance, and strategies
- The study assists marketers and management authorities in making informed decisions regarding product launches, product upgrades, market expansion, and marketing tactics
- The report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Various strategy matrices have been used in analyzing the global drug discount card market to provide stakeholders with ease in decision-making
Drug Discount Card Market Segmentation:
- Drug Discount Card Market, By Type
- Branded Cards
- Generic Cards
- Drug Discount Card Market, By Therapeutic Category:
- Cardiovascular drugs
- Diabetes drugs
- Pain medications
- Mental health medications
- Cancer drugs
- Others
- Drug Discount Card Market, By Sales Channel
- Drug Discount Card Market, By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- GoodRx
- SingleCare
- WellCard Savings
- RxSaver
- Optum Perks
- Kroger Prescription Savings Club
- ScriptSave
- Walmart Rx Savings Program
- Prescription Hope
- FamilyWize
- NeedyMeds
- Humana
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Drug Discount Card, By Type
- Market Drug Discount Card, By Therapeutic Category
- Market Drug Discount Card, By Sales Channel
- Market Drug Discount Card, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- High Cost of Prescription Drugs
- Large Uninsured and Underinsured Population
- Increasing Online Adoption of Online Platform
- Involvement of State Governments to Provide Drug Discounts
- Lack of Awareness among Key Demographics
- Discount Programs by Pharmaceutical Companies as well as Government Organizations
- Expansion into Emerging Markets
- Discount Cards for OTC Drugs
- Customized Services for Employers
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Drug Discount Card Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Drug Discount Card Market, By Type, 2020-2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Branded Cards
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
- Generic Cards
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
6. Drug Discount Card Market, By Therapeutic Category, 2020-2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Cardiovascular drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
- Diabetes drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
- Pain medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
- Mental health medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
- Cancer drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
7. Drug Discount Card Market, By Sales Channel, 2020-2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Online
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
- Offline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
- Senior Citizens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
8. Drug Discount Card Market, By Region, 2020-2032, (US$ Mn)
- Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 - 2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Category, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Category, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Category, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Category, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Category, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032, (US$ Mn)
- GCC
- Israel
- North Africa
- Central Africa
- Rest of Middle East & Africa
9. Competitive Landscape
- GoodRx
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SingleCare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- WellCard Savings
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- RxSaver
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Optum Perks
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Kroger Prescription Savings Club
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- ScriptSave
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Walmart Rx Savings Program
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Prescription Hope
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- FamilyWize
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- NeedyMeds
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Humana
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
관련자료
